You are using an outdated browser. Please upgrade your browser to improve your experience.
J2P-MC-LXBD

A Phase 2, Randomized, Double-Blind, Placebo Controlled, Dose-Ranging Study to evaluate the efficacy and safety of 3 dose levels of BID administered LY3556050 in Adult Participants with Diabetic Peripheral Neuropathic Pain

A Phase 2, Randomized, Double-Blind, Placebo Controlled, Dose-Ranging Study to evaluate the efficacy and safety of 3 dose levels of BID administered LY3556050 in Adult Participants with Diabetic Peripheral Neuropathic Pain

J2P-MC-LXBD

by Medable, Inc.
J2P-MC-LXBD
J2P-MC-LXBD
J2P-MC-LXBD

What is it about?

A Phase 2, Randomized, Double-Blind, Placebo Controlled, Dose-Ranging Study to evaluate the efficacy and safety of 3 dose levels of BID administered LY3556050 in Adult Participants with Diabetic Peripheral Neuropathic Pain

J2P-MC-LXBD

App Details

Version
1.1
Rating
NA
Size
86Mb
Genre
Health & Fitness Medical
Last updated
April 4, 2024
Release date
September 20, 2023
More info

App Store Description

A Phase 2, Randomized, Double-Blind, Placebo Controlled, Dose-Ranging Study to evaluate the efficacy and safety of 3 dose levels of BID administered LY3556050 in Adult Participants with Diabetic Peripheral Neuropathic Pain

Disclaimer:
AppAdvice does not own this application and only provides images and links contained in the iTunes Search API, to help our users find the best apps to download. If you are the developer of this app and would like your information removed, please send a request to takedown@appadvice.com and your information will be removed.